Earnings Release • Aug 6, 2021
Earnings Release
Open in ViewerOpens in native device viewer
Datalogic Confidential Internal
This document has been prepared by Datalogic S.p.A. (the "Company") for use during meetings with investors and financial analysts and is solely for information purposes. The information set out herein has not been verified by an independent audit company. Neither the Company nor any of its subsidiaries, affiliates, branches, representative offices (the "Group"), as well as any of their directors, officers, employees, advisers or agents (the "Group Representatives") accepts any responsibility for/or makes any representation or warranty, express or implied, as to the accuracy, timeliness or completeness of the information set out herein or any other related information regarding the Group, whether written, oral or in visual or electronic form, transmitted or made available. This document may contain forward-looking statements about the Company and/or the Group based on current expectations and opinions developed by the Company, as well as based on current plans, estimates, projections and projects of the Group. These forward-looking statements are subject to significant risks and uncertainties (many of which are outside the control of the Company and/or the Group) which could cause a material difference between forward-looking information and actual future results. The information set out in this document is provided as of the date indicated herein. Except as required by applicable laws and regulations, the Company assumes no obligation to provide updates of any of the aforesaid forward-looking statements. Under no circumstances shall the Group and/or any of the Group Representatives be held liable (for negligence or otherwise) for any loss or damage howsoever arising from any use of this document or its contents or otherwise in connection with the document or the aforesaid forward-looking statements. This document does not constitute an offer to sell or a solicitation to buy or subscribe to Company shares and neither this entire document or a portion of it may constitute a recommendation to affect any transaction or to conclude any legal act of any kind whatsoever.
This document may not be reproduced or distributed, in whole or in part, by any person other than the Company. By viewing and/or accepting a copy of this document, you agree to be bound by the foregoing limitations.
Net Debt at €18.2M, positive NFP at €16.8M excluding MD acquisition
REVENUES €156.6 +40.8% +46.0% Net FX
.
* Including capitalized R&D expenses and excluding D&A
❑ Despite inflationary headwinds H1 Adj EBITDA margin at 16.0%, back to pre-pandemic level thanks to volumes and leaner cost base.
❑ Double digit R&D spending* at 10.0% on revenues, maintaining investment in technology.
❑ EMEAI: leading Group's performance in H1 at +38.1% Net FX, outstanding Q2 at +72.5% Net FX. Sound growth across all
| € m |
H1 2021 | H1 2020 | Var % | Var % Net FX |
|||
|---|---|---|---|---|---|---|---|
| EMEAI | 162.8 | 118.8 | 37.0% | 38.1% | |||
| Americas | 85.6 | 76.3 | 12.2% | 22.5% | |||
| APAC | 43.6 | 35.2 | 23.6% | 26.9% | |||
| Total Datalogic | 292.0 | 230.4 | 26.7% | 31.2% |
❑ Retail: double digit performance in APAC (+26.5% net FX) and EMEAI (+12.0% net FX). Positive booking trend in Americas.
❑ Manufacturing: +42.3% Net FX with solid recovery in Automotive and Packaging in all geographies.
❑ T&L: Outstanding +82.2% growth in H1 Net FX, double digit growth in all region outperforming 2019.
❑ Healthcare: positive trends, especially in EMEAI and APAC, in the hospital sectors and in pharmaceutical distribution.
| Group Revenues by Segment | ||||||||
|---|---|---|---|---|---|---|---|---|
| € m |
H1 2021 | H1 2020 Restated* |
Var % | Var % Net FX |
% on DL Business Revenues | |||
| Retail | 101.8 | 98.9 | 2.9% | 7.2% | Channel 20.6% |
|||
| Manufacturing | 76.2 | 54.7 | 39.3% | 42.3% | ||||
| Transportation & Logistics | 39.1 | 22.3 | 75.5% | 82.2% | Retail Healthcare 35.9% |
|||
| Healthcare | 8.0 | 7.0 | 14.3% | 19.5% | 2.8% | |||
| Channel | 58.4 | 40.3 | 44.8% | 49.3% | T&L | |||
| Total DL Business | 283.5 | 223.2 | 27.0% | 31.3% | 13.8% | |||
| Informatics | 9.0 | 7.9 | 14.2% | 23.9% | Manufacturing | |||
| Intra division | (0.4) | (0.6) | 26.9% | |||||
| Total Datalogic | 292.0 | 230.4 | 26.7% | 31.2% |
*June 30, 2020, comparative data have been restated following the reorganisation of the commercial function launched in 2020.
P2X-SERIES
ALADDIN Configuration Tool
❑ Vitality Index at 11.2% impacted by shortage and lower ramp-up in a Covid context
❑ R&D spending* at 10.0 %. Commitment to Product Development Roadmap continues
* Including capitalized R&D
| ▪ Gross Margin at 45.8% impacted by increased input |
|---|
| costs mainly from the shortage of critical materials and shipping |
| ▪ Operating expenses at €100m steady maintaining a |
| leaner cost base through growth: ✓ R&D costs decrease driven by completion of large |
| Mobile projects ✓ S&D cost decreased by 6.3% due to efficiencies |
| ▪ Adj EBITDA at steady 16.0% |
| ▪ Net Result at €23.5m vs a break even recorded in H1 2020 |
.
| € m | H1 2021 | H1 2020 | Var % |
|---|---|---|---|
| Revenues | 292.0 | 230.4 | 26.7% |
| Gross Margin | 133.7 | 105.9 | |
| % on Revenues | 45.8% | 46.0% | -0.2 pp |
| Operating expenses | (100.3) | (99.5) | |
| % on Revenues | (34.3%) | (43.2%) | +8.8 pp |
| Adjusted EBITDA | 46.8 | 18.4 | |
| % Adj. Ebitda margin | 16.0% | 8.0% | +8.1 pp |
| EBIT | 28.2 | 0.3 | |
| % Ebit margin | 9.7% | 0.1% | +9.5 pp |
| Net Result | 23.5 | (0.0) | |
| % on Revenues | 8.1% | (0.0%) | +8.1 pp |
€ m
.
* Including IFRS 16 impact
▪ Growth consolidating and accelerating in almost all geographies and all the main market segments in which the Group
▪ Despite uncertainty continues, the strong order intake growth in all geographical areas, and an exceptionally high
▪ Assuming that the pandemic crisis, supply shortages and the resulting inflation do not escalate further, the Group confirms for the current year its revenue growth target of between 16% and 20%, with an improvement in EBITDA
IR Manager Laura Bernardelli Tel. +39 051 3147109 [email protected] Via Candini, 2 40012 Lippo di Calderara di Reno Bologna – Italy
IR Advisor Vincenza Colucci CDR Communication Srl Tel. +39 335 6909547 [email protected]
IR Assistant Daniela Giglioli Tel. +39 051 3147109 Fax +39 051 3147205 [email protected]
www.datalogic.com
September 08, 2021 Industrial Day 2021 – Borsa Italiana
November 11, 2021 9M 2021 Results
This presentation contains statements that are neither reported financial results nor other historical information. These statements are forward-looking statements. These forward-looking statements rely on a number of assumptions and are subject to a number of risks and uncertainties, many of which are outside the control of Datalogic S.p.A., that could cause actual results to differ materially from those expressed in or implied by such statements, such as future market conditions, currency fluctuations, the behavior of other market participants and the actions of governmental and state regulators
© 2019 Datalogic S.p.A. and/or its affiliates - All rights reserved. • Without limiting the rights under copyright, no part of this documentation may be reproduced, stored in or introduced into a retrieval system, or transmitted in any form or by any means, or for any purpose, without the express written permission of Datalogic S.p.A. and/or its affiliates • Datalogic and the Datalogic logo are registered trademarks of Datalogic S.p.A. in many countries, including the U.S. and the E.U. • All other trademarks and brands are property of their respective owners.
Via Candini, 2 - 40012 Lippo di Calderara di Reno - Bologna (Italy) Tel. +39 051 3147011 | Fax +39 051 3147205 [email protected] ww.datalogic.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.